Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy Subjects

NCT06360445 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Olaparib Tablet test formulation 100mg
DRUG: Olaparib Tablet reference formulation 100mg
DRUG: Olaparib Tablet test formulation 150mg
DRUG: Olaparib Tablet reference formulation 150mg

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.